This inventor holds 4 USPTO granted patents and 5 published patent applications and 4 EPO patents. Top assignees: Constellation Pharmaceuticals, Inc., Genentech, Inc.. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 56 
4 out of 3,304 
Years Active: 2018-2019
Title: The Innovations of Andrew Charles Good
Introduction
Andrew Charles Good is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of therapeutic compounds, holding a total of 4 patents. His work focuses on innovative methods for treating various disorders, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Among his latest patents, one invention relates to therapeutic compounds and their uses for treating PCAF mediated disorders. This invention involves a compound of formula (I) or a pharmaceutically acceptable salt thereof, with specific values defined in the specification. Another patent also addresses therapeutic compounds of formula (I) and salts thereof, which are useful as inhibitors of BRG1, BRM, and/or PB1. These compounds and their pharmaceutical compositions are designed for the treatment of various BRG1-mediated, BRM-mediated, and PB1-mediated disorders.
Career Highlights
Andrew has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and Constellation Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of therapeutic solutions.
Collaborations
Throughout his career, Andrew has collaborated with talented individuals such as Brian K. Albrecht and Alexandre Cote. These partnerships have fostered a creative environment that has led to groundbreaking inventions in the field of therapeutics.
Conclusion
Andrew Charles Good is a distinguished inventor whose work in therapeutic compounds has the potential to impact the treatment of various medical disorders. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile